Volta
A SARS-CoV-2 and influenza rapid antigen test-based hospital isolation policy awaiting RT-PCR, a prospective observational study
Unknown authors
· 2023
hash_id: 6b6c31d05f4cb8fb82144b8053f533b929679e73371e26aaa912443817708770
· DOI: 10.1016/j.cmi.2023.09.011
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection | secondary |